Department of Obstetrics and Gynecology, Tampere University Hospital, Finland (A.K., E.T., H.L.).
Center for Child, Adolescent, and Maternal Health, Faculty of Medicine and Health Technology (A.K., E.T., J.T., H.L.), Tampere University, Finland.
Hypertension. 2022 Sep;79(9):2008-2015. doi: 10.1161/HYPERTENSIONAHA.122.18996. Epub 2022 Jul 7.
Preeclampsia causes significant maternal and perinatal morbidity. Genetic factors seem to affect the onset of the disease. We aimed to investigate whether the polygenic risk score for blood pressure (BP; BP-PRS) is associated with preeclampsia, its subtypes, and BP values during pregnancy.
The analyses were performed in the FINNPEC study (Finnish Genetics of Pre-Eclampsia Consortium) cohort of 1514 preeclamptic and 983 control women. In a case-control setting, the data were divided into percentiles to compare women with high BP-PRS (HBP-PRS; >95th percentile) or low BP-PRS (≤5th percentile) to others. Furthermore, to evaluate the effect of BP-PRS on BP, we studied 3 cohorts: women with preeclampsia, hypertensive controls, and normotensive controls.
BP values were higher in women with HBP-PRS throughout the pregnancy. Preeclampsia was more common in women with HBP-PRS compared with others (71.8% and 60.1%, respectively; =0.009), and women with low BP-PRS presented with preeclampsia less frequently than others (44.8% and 61.5%, respectively; <0.001). HBP-PRS was associated with an increased risk for preeclampsia (odds ratio, 1.7 [95% CI, 1.1-2.5]). Furthermore, women with HBP-PRS presented with recurrent preeclampsia and preeclampsia with severe features more often.
Our results suggest that HBP-PRS is associated with an increased risk of preeclampsia, recurrent preeclampsia, and preeclampsia with severe features. Furthermore, women with HBP-PRS present higher BP values during pregnancy. The results strengthen the evidence pointing toward the role of genetic variants associated with BP regulation in the etiology of preeclampsia, especially its more severe forms.
子痫前期会导致产妇和围产儿发病率显著增加。遗传因素似乎会影响疾病的发作。我们旨在研究血压多基因风险评分(BP-PRS)是否与子痫前期、其亚型以及妊娠期间的血压值有关。
该分析在 FINNPEC 研究(芬兰子痫前期遗传学联合会)队列的 1514 例子痫前期和 983 例对照女性中进行。在病例对照研究中,数据按百分位数进行划分,以比较高 BP-PRS(HBP-PRS;>95 百分位数)或低 BP-PRS(≤5 百分位数)女性与其他女性。此外,为了评估 BP-PRS 对血压的影响,我们研究了 3 个队列:子痫前期妇女、高血压对照组和正常血压对照组。
整个孕期 HBP-PRS 女性的血压值更高。与其他女性相比,HBP-PRS 女性子痫前期更常见(分别为 71.8%和 60.1%;=0.009),而低 BP-PRS 女性子痫前期较少见(分别为 44.8%和 61.5%;<0.001)。HBP-PRS 与子痫前期的风险增加相关(比值比,1.7 [95%置信区间,1.1-2.5])。此外,HBP-PRS 女性更常发生复发性子痫前期和伴有严重特征的子痫前期。
我们的研究结果表明,HBP-PRS 与子痫前期、复发性子痫前期和伴有严重特征的子痫前期风险增加有关。此外,HBP-PRS 女性在妊娠期间的血压值更高。这些结果进一步证实了与血压调节相关的遗传变异在子痫前期发病机制中的作用,尤其是在子痫前期的更严重形式中。